Posted 30 July, 2021
Rallybio Corp IPO completed
IPO completed detected for ticker Nasdaq:RLYB in a 424B4 filed on 30 July, 2021.
This is an initial public offering.
Don't know how to trade IPO completion? Read Initial Public Offerings.
Overview of Rallybio Corp
Health Care/Life Sciences • Pharmaceuticals
Rallybio Corp. engages in the identification, research and development, and manufacture of clinical biotechnology products and therapies for severe and rare diseases. Its product candidates focus on the areas of fetal and neonatal disorders, hematology, immuno-inflammation, and metabolic disease. The company was founded by Martin W. Mackay, Stephen Uden, and Jeffrey M. Fryer in January 2018 and is headquartered in New Haven, CT.Market Cap
$74.5M
View Company Details
$74.5M
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.